| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 03/09/2006 | CA2577398A1 Urea derivatives as calcium channel blockers |
| 03/09/2006 | CA2577392A1 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors |
| 03/09/2006 | CA2576830A1 Arylamine ketones, their preparation methods, the pharmaceutical compositions containing them and their use |
| 03/09/2006 | CA2576782A1 Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors |
| 03/09/2006 | CA2576718A1 Method for preparing n-aminopiperedine and its salts |
| 03/08/2006 | EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 03/08/2006 | EP1632479A2 Piperazine derivatives useful as ccr5 antagonists |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1632230A1 Neurocyte protective agent |
| 03/08/2006 | EP1631557A1 Cyclic hydroxylamine as psychoactive compounds |
| 03/08/2006 | EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 03/08/2006 | EP1631355A1 Piperidinyl prostaglandin e analogs |
| 03/08/2006 | EP1631286A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 03/08/2006 | EP1631285A1 Therapeutic agents useful for treating pain |
| 03/08/2006 | EP1539734B1 Piperidine quinolyl propyl derivatives and use thereof as antimicrobial agents |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1451167B1 Phenylalkynes |
| 03/08/2006 | EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 03/08/2006 | EP1365761B1 Therapeutic combination of amlodipine and benazepril |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | EP1198454B1 Mutilin derivatives and their use as antibacterials |
| 03/08/2006 | EP0977568B1 Benzocycloheptathiophene compounds |
| 03/08/2006 | CN1744895A N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244560C Method for preparing 4-haloalkyl nicotine nitriles |
| 03/07/2006 | US7008955 (2-azabicyclo[2.2.1]hept-7yl) methanol derivatives as nicotinic acetylcholine receptor agonists |
| 03/07/2006 | US7008952 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/02/2006 | WO2006023187A2 Cycloalkylamine derivatives as nk-1 /ssri antagonists |
| 03/02/2006 | WO2006021806A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
| 03/02/2006 | WO2006021805A1 Diarylsulfones as 5-ht2a antagonists |
| 03/02/2006 | WO2006021656A2 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 03/02/2006 | WO2005123679A3 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/02/2006 | US20060047116 Such as N-methyl(1-{2-[(1R,5S)-3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-2,3-dihydro-1H-inden-1-yl)methanamine; chemokine receptor antagonists; prevention or treatment of a human T-cell leukemia/lymphoma virus infection |
| 03/02/2006 | US20060046999 Monocyclic aroylpyridinones as antiinflammatory agents |
| 03/02/2006 | US20060046966 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 03/02/2006 | CA2578115A1 O-aminophenol derivatives and dyes containing these compounds |
| 03/02/2006 | CA2577837A1 Diarylsulfones as 5-ht2a antagonists |
| 03/02/2006 | CA2575200A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 03/02/2006 | CA2575078A1 Lercanidipine salts |
| 03/02/2006 | CA2574454A1 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 03/01/2006 | EP1628960A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 03/01/2006 | EP1628959A2 Crystalline forms of fexofenadine hydrochloride and processes for their preparation |
| 03/01/2006 | EP1628685A2 Antiviral phosphonate analogs |
| 03/01/2006 | CN1742017A Antiprotozoal ring-substituted phospholipids |
| 03/01/2006 | CN1742004A Indazolamides with analgesic activity |
| 03/01/2006 | CN1741993A Process for producing cyclic amine |
| 03/01/2006 | CN1741981A Process for the preparation of fexofenadine |
| 03/01/2006 | CN1740157A Synthesis process of N-sustituent-4-piperidyl alcohol |
| 03/01/2006 | CN1740156A Diastereomeric salts of terfenadine |
| 03/01/2006 | CN1243737C Immunoregulator for inhibiting interleukin-4, stimulus g interferon and preparing method thereof |
| 03/01/2006 | CN1243724C Amide derivatives which are useful as cell factor inhibitors |
| 02/28/2006 | US7005524 Piperidine compounds such as 1-(2-phenylethyl)-3-(1-(phenylamino)ethyl)piperidine useful as or intermediates to compounds that treat conditions and diseases that afflict mammals, including addiction and pain |
| 02/28/2006 | US7005439 Compounds |
| 02/28/2006 | US7005437 Substituted aryl and heteroaryl derivatives, the preparation thereof and the use therof as pharmaceutical compositions |
| 02/28/2006 | US7005436 Heterocyclo inhibitors of potassium channel function |
| 02/28/2006 | US7005435 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | CA2347469C Esters of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 100,907 |
| 02/23/2006 | WO2006018815A1 Piperazine derivatives as adrenergic receptor antagonists |
| 02/23/2006 | US20060041144 Phenylpyridine compound and fungicidal compostion containing the same |
| 02/23/2006 | US20060041141 4-Methylpropiophenone is reacted with piperidine hydrochloride and 1,3-dioxolane in the presence of an acid serving as a catalyst, and the tolperisone obtained in the form of an acid addition salt is separated by filtering after the reaction mixture has cooled down; improved purity, simplification |
| 02/23/2006 | US20060041140 5,6-dimethoxy-2-(4-pyridyl)methyl-1-indanone is hydrogenated using platinum oxide catalyst in the presence of hydrochloric acid under a pressure of 2 bars to give 4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride |
| 02/23/2006 | US20060041139 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 02/23/2006 | US20060041020 Alzheimer's disease, modulate the processing of amyloid precursor protein by gamma-secretase |
| 02/23/2006 | US20060041014 Treatment of male sexual dysfunction |
| 02/23/2006 | US20060040989 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 02/23/2006 | US20060040987 "soft" analog of fentanyl; derivative of 1,4-disubstituted piperdine compounds; opioid receptor agonist; analgesic; high degree of efficiency against extreme pain; less side effects then fentanyl; oral bioavailability |
| 02/23/2006 | US20060040986 Erythropoietin production accelerator |
| 02/23/2006 | US20060040985 Therapeutic agent for treating respiratory diseases containing 4-hydroxypiperidine derivative as active ingredient |
| 02/23/2006 | US20060040984 Novel piperidine derivatives for use in the treatment of chemokine medicated disease states |
| 02/23/2006 | US20060040922 Aripiprazole, olanzapine and haloperidol pamoate salts |
| 02/23/2006 | US20060040906 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 02/23/2006 | DE102004037911A1 New mixed cage dimers of 4-phenyl-1,4-dihydropyridine derivatives, useful as HIV-1 protease inhibiting anti-HIV agents which also modulate HIV resistance by inhibiting P-glycoprotein |
| 02/23/2006 | DE102004037885A1 New cage dimers of 4-phenyl-1,4-dihydropyridine derivatives, useful as HIV-1 protease inhibiting anti-HIV agents and for increasing resorption and bioavailability of other anti-HIV drugs |
| 02/23/2006 | CA2578098A1 Hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl) benzamide, methods for the production thereof, and use thereof as medicaments |
| 02/23/2006 | CA2576993A1 Bisaryl-sulfonamides |
| 02/22/2006 | EP1627871A1 Cyclic aminophenyl sulfamate derivative |
| 02/22/2006 | EP1626961A1 Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same |
| 02/22/2006 | EP1626960A1 Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists |
| 02/22/2006 | EP1626959A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 02/22/2006 | EP1626958A1 (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht 1f agonists |
| 02/22/2006 | EP1626720A1 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors |
| 02/22/2006 | EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | CN1738801A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 02/22/2006 | CN1738800A 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 02/22/2006 | CN1738799A Methods for preparing phenylalkyne derivatives |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/22/2006 | CN1736982A Process for the preparation of 4-haloalkylnicotinonitriles |
| 02/22/2006 | CN1736980A Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 02/22/2006 | CN1242991C Aporphine esters and their use in therapy |
| 02/22/2006 | CN1242989C Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7002018 Process for the preparation of amorphous form of torsemide |
| 02/21/2006 | US7002016 reacting 1-(phenylglyoxylyl)piperidine arenesulfonylhydrazone in dichloromethane or toluene with base and phase transfer catalyst, to form (R*,R*)-enriched 7-phenyl-1-azabicyclo[4.2.0]octan-8-one; ring opening with methanol and hydrochloric acid |
| 02/21/2006 | US7002015 3-Thia-4-arylquinolin-2-one derivatives as smooth muscle relaxants |
| 02/21/2006 | US7001915 Ultrashort-acting opioids for transdermal applications |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/16/2006 | WO2006016637A1 Novel cyclic aminobenzoic acid derivative |
| 02/16/2006 | WO2006016203A1 An improved process for the preparation of irinotecan hydrochloride trihydrate |